Moderna shares fell more than 5% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine.

Trump Administration Weighs Pulling Funding for Moderna Bird Flu Vaccine, Bloomberg News Reports (Reuters) - U.S. health officials are reevaluating a $590 million contract that was awarded to ...

Además, se ofrecerán opciones de formación presencial y virtual para adaptarse a las necesidades de todas las personas participantes. Los primeros cursos que abordará el Aula de Formación Permanente ...

Además, se ofrecerán opciones de formación presencial y virtual para adaptarse a las necesidades de todas las personas participantes. Los primeros cursos que abordará el Aula de Formación Permanente ...

Moderna posted a Q4 EPS loss of $(2.91), missing estimates, while revenue fell to $966M from $2.81B but beat the $942.8M consensus Moderna’s norovirus vaccine trial is on FDA hold due to a ...

Looking ahead to 2025, Moderna expects revenue of $1.5 to $2.5bn. Credit: Tada Images/Shutterstock. Moderna has reported revenue of $1bn for the fourth quarter (Q4) of 2024 – a sharp decline from the ...

(Bloomberg) -- Moderna Inc. recorded another quarterly loss as vaccine sales wane and the company had an unexpected charge for a canceled manufacturing contract. The Cambridge, Massachusetts-based ...

The move from conventional to virtual retail has made an important economic shift globally. The total value of e-commerce sales internationally in 2023 was around $5.8 trillion, a rise of almost 9 ...

Dirigido a personas interesadas en la sostenibilidad alimentaria y nutricional, así es el aula de extensión universitaria que se celebrará en Soto de Ribera que lleva el sobrenombre de "De la ...

A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological disorder. The phase 3 study is evaluating the candidate, dubbed mRNA-1403 ...